Stuart D. Rosen

Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society

Alexander R. Lyon, Susan Dent, Susannah Stanway et al. · European Journal of Heart Failure · 2020 · 770 citations · Full text

Medicine, Cardiology, Oncology +16

Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial

Brian P. Halliday, Rebecca Wassall, Amrit Lota et al. · The Lancet · 2018 · 636 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Association Between Midwall Late Gadolinium Enhancement and Sudden Cardiac Death in Patients With Dilated Cardiomyopathy and Mild and Moderate Left Ventricular Systolic Dysfunction

Brian P. Halliday, Ankur Gulati, Aamir Ali et al. · Circulation · 2017 · 373 citations · Full text

Medicine, Cardiology, Internal Medicine +17

Genetic Variants Associated With Cancer Therapy–Induced Cardiomyopathy

Pablo García‐Pavía, Yuri Kim, María Alejandra Restrepo-Córdoba et al. · Circulation · 2019 · 344 citations · Full text

Medicine, Genetics, Oncology +13

Breathlessness in humans activates insular cortex

Robert B. Banzett, Henrietta Mulnier, Kevin Murphy et al. · Neuroreport · 2000 · 342 citations

Life Sciences, Neurobiology, Neuroscience +17